title: Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study).
authors.affiliation: Department of Rheumatology, Clinical Research Center for Rheumatic Diseases, NHO Kumamoto Saishunsou National Hospital, Kohshi, Kumamoto, Japan.
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Mori
authors.affiliation: Yoshitama Clinic for Rheumatic Diseases, Kirishima, Kagoshima, Japan.
authors.forename: Tamami
authors.initials: T
authors.lastname: Yoshitama
authors.affiliation: Institute of Rheumatology, Zenjinkai Shimin-no-Mori Hospital, Miyazaki, Japan.
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Hidaka
authors.affiliation: Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Nagasaki, Japan.
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Hirakata
authors.affiliation: Rheumatic and Collagen Disease Center, Sasebo Chuo Hospital, Sasebo, Nagasaki, Japan.
authors.forename: Yukitaka
authors.initials: Y
authors.lastname: Ueki
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D012042:Registries; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; C502936:tocilizumab
keywords: Methotrexate; Outcomes research; Rheumatoid Arthritis; Treatment